About ERIX
EiRx Therapeutics is a specialist provider of pre-clinical therapeutics to the pharmaceutical industry. Our unique scientific expertise and knowledge in the field of Apoptosis provide a sound base to discover and develop new medicines that will safely and selectively repair this natural process in disease. The potential benefits from these new medicines are enormous, since as many as 70% of all human disease have some defect in the control of Apoptosis.
Apoptosis - the biological process that determines whether cells in our bodies live or die...
http://www.eirx.com/index.html

Purchased some of these on the strength of the PROGRESS UPDATE looks promising.
http://moneyam.uk-wire.com/cgi-bin/articles/200603200701130254A.html

ERX interview with John Pool
http://www.wallstreetreporter.com/interview.php?id=18589&player=real
Latest News
CANCER COLLABORATION WITH BIOMERIEUX SA
http://moneyam.uk-wire.com/cgi-bin/articles/200607120700230534G.html
Biomerieux Web Site
http://www.biomerieux.com/servlet/srt/bio/portail/home
ABOUT ERX Focus Of The Month
http://www.billamag.net/focus-document-text.asp?FocusTextID=1
ERX pdf filehttp://www.eirx.com/eirx_heading_images/Yokohama2005.pdf
19/09/2006 A 50% reduction in breast tumour volume size seen with Eirx lead molecule in animal studies
http://moneyam.uk-wire.com/cgi-bin/articles/200609190700171175J.html

Past and present collaborative partners include:

* bioMieux SA
* Almac Diagnostics Ltd
* Merck & Co, Ltd
* Biofocus plc
* MGI Pharmaceuticals, Inc
* OSI Pharmaceuticals, Inc
* Sareum plc
* Regen Therapeutics plc
* SR Pharma plc

PH-what are you on???

DONT KNOW WHY ANYBODY TAKES ANY NOTICE OF PH.

HenryFord - 7 Dec'06 - 20:05 - 14498 of 14516

BioMerieux, awarded 54.5m, will focus on the development of new molecular diagnostic platforms to perform high-added-value analyses of infectious diseases and cancers.

http://www.drugresearcher.com/news/ng.asp?n=72476-merieux-alliance-transgene-aii-personalised-medicine-biomerieux

getting back to the RELEVANT RESEARCH

HenryFord - 7 Dec'06 - 20:07 - 14499 of 14516

http://www.investegate.co.uk/Article.aspx?id=200607120700230534G

Cannoncan - 7 Dec'06 - 20:33 - 14500 of 14516 edit

;-)

HenryFord - 7 Dec'06 - 20:44 - 14501 of 14516

You can clearly see the "Personalised Medicine" Potential in the diagnostic side of Eirx. It's on a par commercially with a blockbusting drug down the road.
You can also see that its the Colerectal Cancer Research of Eirx that BioMeriux are clearly after, a collaboration with a $2B sales pa company and reciprocal IP deal is clearly not to be sniffed at.

HenryFord - 8 Dec'06 - 10:40 - 14547 of 14548


from the interview.

"compounds shortly to go into clincical trials and license them out to majors and these are conversations that are progressing at the moment"

"not far off producing efficaious compounds for Colorecteral Cancer"

And intellectual property owners of more than 50% of the known targets in the world.

This was said in June or July?
When the price was 0.3p.
BEFORE we got the Breast Cancer news.

The Bowel Cancer news is likely to be along next, and also the Breast Cancer Compound License news.

Just reminding myself
Thought you research aces would appreciate that!

HenryFord - 8 Dec'06 - 10:43 - 14548 of 14548


and all for 6m. that looks like 20 times too cheap to me

i think this news is pretty major, my reckoning we will get more news than bargained for

HenryFord - 7 Dec'06 - 20:05 - 14498 of 14516

BioMerieux, awarded 54.5m, will focus on the development of new molecular diagnostic platforms to perform high-added-value analyses of infectious diseases and cancers.

http://www.drugresearcher.com/news/ng.asp?n=72476-merieux-alliance-transgene-aii-personalised-medicine-biomerieux

getting back to the RELEVANT RESEARCH

HenryFord - 7 Dec'06 - 20:07 - 14499 of 14516

http://www.investegate.co.uk/Article.aspx?id=200607120700230534G

Cannoncan - 7 Dec'06 - 20:33 - 14500 of 14516 edit

;-)

HenryFord - 7 Dec'06 - 20:44 - 14501 of 14516

You can clearly see the "Personalised Medicine" Potential in the diagnostic side of Eirx. It's on a par commercially with a blockbusting drug down the road.
You can also see that its the Colerectal Cancer Research of Eirx that BioMeriux are clearly after, a collaboration with a $2B sales pa company and reciprocal IP deal is clearly not to be sniffed at.

PH

News at 17.30

(every day on channel 5)

ON THE MOVE UP

NEWS AT 2PM OBVIOUSLY

Luckypicker - 8 Dec'06 - 13:51 - 14594 of 14599


"John K Pool"
13/11/2006 17:14
To

cc

Subject
Re: Shareholder Question





We are looking at producing an analysts note currently We are not
considering going back to the market, if at all, without some very
significant news
John
----- Original Message -----
From:
To: "John K Pool"
Sent: Monday, November 13, 2006 5:10 PM
Subject: Re: Shareholder Question


> John,
>
> Yes I understand this, but my concern is if we dont get some cash soon ERX
> will run out of cash and turn to the market, which I really am hopeing
> this
> will not be the case. I am hopeing the milestone payments will fund us for
> a number of years.
>
> As you know I commented on the marketing, we have changed broker but no
> broker update, I have noted some PI's have asked Seymore pierce why there
> is no broker note, and they say there is none, why not???, this I believe
> is putting many potential investors off.
>
> I look forward to receiving the annual report
>
> Kind regards

significant news coming

Wake me up when the bid price gets to 1p please!

laurie
I thought you would still be awake after GOO yesterday and today.

dont think we can go wrong with this one

news is def next week

2pm?

what time?

Driver comatosed from the hangover instead!

news at 5pm

POST OF THE DAY!!!!

Luckypicker - 8 Dec'06 - 13:51 - 14594 of 14599


"John K Pool"
13/11/2006 17:14
To

cc

Subject
Re: Shareholder Question





We are looking at producing an analysts note currently, We are not
considering going back to the market, if at all, without some very
significant news
John
----- Original Message -----
From:
To: "John K Pool"
Sent: Monday, November 13, 2006 5:10 PM
Subject: Re: Shareholder Question


> John,
>
> Yes I understand this, but my concern is if we dont get some cash soon ERX
> will run out of cash and turn to the market, which I really am hopeing
> this
> will not be the case. I am hopeing the milestone payments will fund us for
> a number of years.
>
> As you know I commented on the marketing, we have changed broker but no
> broker update, I have noted some PI's have asked Seymore pierce why there
> is no broker note, and they say there is none, why not???, this I believe
> is putting many potential investors off.
>
> I look forward to receiving the annual report
>
> Kind regards

THIS IS THE BIT I LIKE

We are not considering going back to the market, if at all, without some very
significant news

POST OF THE DAY!!!!

PH is still posting on our thread, so he hasn't sold yet.